Sandra Garofalo, APRN

NPI: 1689221905
Total Payments
$11,860
2024 Payments
$9,212
Companies
49
Transactions
204
Medicare Patients
1,408
Medicare Billing
$107,197

Payment Breakdown by Category

Food & Beverage$5,986 (50.5%)
Consulting$2,748 (23.2%)
Other$2,164 (18.2%)
Travel$692.67 (5.8%)
Education$269.99 (2.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $5,986 182 50.5%
Consulting Fee $2,748 3 23.2%
Long term medical supply or device loan $1,196 12 10.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $967.50 1 8.2%
Travel and Lodging $692.67 3 5.8%
Education $269.99 3 2.3%

Top Paying Companies

Company Total Records Latest Year
Regeneron Pharmaceuticals, Inc. $2,568 11 $0 (2024)
Genentech USA, Inc. $1,521 7 $0 (2024)
Novartis Pharmaceuticals Corporation $1,453 27 $0 (2024)
JAZZ PHARMACEUTICALS INC. $967.50 1 $0 (2024)
AstraZeneca Pharmaceuticals LP $433.59 11 $0 (2024)
Incyte Corporation $395.11 6 $0 (2024)
PFIZER INC. $359.13 17 $0 (2024)
E.R. Squibb & Sons, L.L.C. $353.03 5 $0 (2024)
ABBVIE INC. $295.79 11 $0 (2024)
GENZYME CORPORATION $250.36 11 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $9,212 140 Regeneron Pharmaceuticals, Inc. ($2,568)
2023 $1,441 42 AstraZeneca Pharmaceuticals LP ($207.42)
2022 $965.22 17 Myriad Genetic Laboratories, Inc. ($168.48)
2021 $242.46 5 PUMA BIOTECHNOLOGY, INC. ($125.00)

All Payment Transactions

204 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
12/20/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $30.58 General
12/18/2024 PFIZER INC. INLYTA (Drug), PADCEV Food and Beverage In-kind items and services $19.23 General
Category: ONCOLOGY
12/17/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $99.33 General
12/11/2024 Amgen Inc. Blincyto (Biological) Food and Beverage In-kind items and services $107.58 General
Category: Oncology
12/10/2024 Novartis Pharmaceuticals Corporation KISQALI (Drug) Long term medical supply or device loan In-kind items and services $99.70 General
Category: Oncology
12/06/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $22.04 General
Category: ONCOLOGY
12/02/2024 Rigel Pharmaceuticals, Inc. Rezlidhia (Drug), Tavalisse Food and Beverage Cash or cash equivalent $18.13 General
Category: Acute Myeloid Leukemia
11/20/2024 Janssen Biotech, Inc. DARZALEX (Biological), TECVAYLI, TALVEY Food and Beverage In-kind items and services $25.38 General
Category: Oncology
11/18/2024 GENZYME CORPORATION SARCLISA (Biological) Food and Beverage In-kind items and services $27.07 General
Category: Oncology
11/15/2024 PUMA BIOTECHNOLOGY, INC. Food and Beverage In-kind items and services $18.34 General
11/14/2024 Novartis Pharmaceuticals Corporation KISQALI (Drug) Long term medical supply or device loan In-kind items and services $99.70 General
Category: Oncology
11/13/2024 Novartis Pharmaceuticals Corporation KISQALI (Drug) Food and Beverage In-kind items and services $14.45 General
Category: Oncology
11/12/2024 Incyte Corporation Education Cash or cash equivalent $99.00 General
11/12/2024 Janssen Biotech, Inc. RYBREVANT (Drug) Food and Beverage In-kind items and services $41.91 General
Category: Oncology
11/11/2024 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $127.40 General
Category: Hematology/Oncology
11/06/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $132.12 General
Category: Oncology
11/06/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $27.14 General
Category: Rare Disease
11/04/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), LYNPARZA Food and Beverage In-kind items and services $27.72 General
Category: ONCOLOGY
11/01/2024 SOBI, INC SYNAGIS (Drug) Food and Beverage In-kind items and services $23.25 General
Category: IMMUNOLOGY
10/30/2024 TerSera Therapeutics LLC Zoladex (Drug) Food and Beverage In-kind items and services $29.01 General
Category: Oncology
10/25/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $25.31 General
Category: ONCOLOGY
10/25/2024 Novartis Pharmaceuticals Corporation KISQALI (Drug) Food and Beverage In-kind items and services $3.67 General
Category: Oncology
10/24/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $34.73 General
10/23/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological), REBLOZYL, WELIREG Food and Beverage In-kind items and services $26.95 General
Category: ONCOLOGY
10/21/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $28.77 General
Category: ONCOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 146 170 $66,241 $13,420
2022 5 229 254 $78,137 $16,011
2021 5 334 449 $104,436 $29,150
2020 12 699 7,798 $201,996 $48,616
Total Patients
1,408
Total Services
8,671
Medicare Billing
$107,197
Procedure Codes
26

All Medicare Procedures & Services

26 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 95 118 $45,831 $9,289 20.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 22 22 $12,100 $2,484 20.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 29 30 $8,310 $1,646 19.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 110 132 $49,968 $9,895 19.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 32 34 $17,680 $3,587 20.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 28 28 $7,161 $1,355 18.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 14 14 $2,254 $880.60 39.1%
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count Office 2022 33 33 $957.00 $254.49 26.6%
36415 Insertion of needle into vein for collection of blood sample Office 2022 12 13 $117.00 $39.00 33.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 147 233 $65,706 $18,223 27.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 101 127 $24,384 $6,551 26.9%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 32 35 $13,300 $4,080 30.7%
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count Office 2021 28 28 $812.00 $217.56 26.8%
36415 Insertion of needle into vein for collection of blood sample Office 2021 26 26 $234.00 $78.00 33.3%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 196 337 $95,034 $22,395 23.6%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 69 86 $32,680 $7,536 23.1%
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Office 2020 11 6,630 $13,260 $5,355 40.4%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 102 113 $21,696 $5,188 23.9%
96413 Infusion of chemotherapy into a vein up to 1 hour Office 2020 22 36 $14,868 $2,789 18.8%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 34 42 $7,980 $1,981 24.8%
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test Office 2020 100 146 $4,234 $1,121 26.5%
96367 Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Office 2020 18 45 $4,635 $834.16 18.0%
96365 Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Office 2020 17 19 $3,553 $704.47 19.8%
36415 Insertion of needle into vein for collection of blood sample Office 2020 93 134 $1,206 $397.44 33.0%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2020 24 40 $2,680 $299.52 11.2%

About Sandra Garofalo, APRN

Sandra Garofalo, APRN is a Nurse Practitioner healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2019. The National Provider Identifier (NPI) number assigned to this provider is 1689221905.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sandra Garofalo, APRN has received a total of $11,860 in payments from pharmaceutical and medical device companies, with $9,212 received in 2024. These payments were reported across 204 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($5,986).

As a Medicare-enrolled provider, Garofalo has provided services to 1,408 Medicare beneficiaries, totaling 8,671 services with total Medicare billing of $107,197. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Other Specialties Gerontology
  • Location Indianapolis, IN
  • Active Since 08/21/2019
  • Last Updated 12/02/2024
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1689221905

Products in Payments

  • Venclexta (Biological) $1,350
  • KISQALI (Drug) $1,280
  • JAKAFI (Drug) $277.40
  • OPDIVO (Biological) $259.18
  • REBLOZYL (Biological) $185.59
  • KEYTRUDA (Biological) $174.67
  • myRisk (Device) $168.48
  • SARCLISA (Biological) $167.29
  • VENCLEXTA (Drug) $164.78
  • TUKYSA (Drug) $151.55
  • IMFINZI (Biological) $134.34
  • EPKINLY (Drug) $131.01
  • LUMAKRAS (Drug) $131.00
  • Lenvima (Drug) $128.60
  • NERLYNX (Drug) $125.00
  • XPOVIO (Drug) $125.00
  • ADCETRIS (Biological) $123.99
  • TECENTRIQ (Biological) $118.91
  • AYVAKIT (Drug) $114.58
  • Blincyto (Biological) $107.58

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Indianapolis